Investor and now Investment Advisor at TA Capital with 35 years of investment experience beginning in 1980 during my college days at West Point. As a professional, I was a Financial Advisor / VP for almost 10 years from 1994 until 2003 at (Dean Witter) Morgan Stanley and Prudential Securities and I recently joined TA Capital having received my Series 65 in November 2015. I earned my MBA from Kellogg at Northwestern University, expanding my investment knowledge and skills ... but nothing beats 'the school of hard knocks'. I have been focused on equity investing and experienced and suffered through all of the major and minor market corrections since 1980. So, I have the intestinal fortitude and a very strong stomach for risk (volatility). Having read numerous articles on Seeking Alpha, I decided that my views can offer some value, especially since I put 'my money where my mouth is' with skin in the game just as I did as an investment professional. I have been particularly focused on options for the past 10 years and you can NEVER stop learning how to employ these tools. I am typically a contrarian and longer-term investor and do not follow the hoard mentality. I am not a momentum player unless I can be extremely nimble with the 'trade'. I value the views of others, especially those with the credibilty, expertise and 'chops' for their analyses and prognostications. But I do my own homework when it comes to the fundamentals - I adhere to the Caveat Emptor (Buyer Beware) concept.
After having been in the investing world for more than 25 years from private banking and investment management to private and venture capital; I have pretty much "been there and done that" at one point or another. I am currently a silent partner for an RIA in Houston, Texas.
The majority of my time is spent analyzing, researching and writing commentary about investing, investor psychology and macro-views of the markets and the economy. My thoughts are not generally mainstream and are often contrarian in nature but I try an use a common sense approach, clear explanations and my “real world” experience in the process.
I am the Chief Editor of the REAL INVESTMENT REPORT, a weekly subscriber based-newsletter that is distributed nationwide. The newsletter covers economic, political and market topics as they relate to your money and life.
I also write a daily blog which is read by thousands nationwide from individuals to professionals at www.realinvestmentadvice.com.
Chris DeMuth Jr. is the founder of Rangeley Capital LLC. Rangeley is an investment firm that focuses on event driven, value-oriented investment opportunities. Rangeley Capital and his value investing forum, Sifting the World (StW), search the world for misplaced bets. Rangeley exploits them for its investors and then Mr. DeMuth writes about them on StW.
MD, MBA (NYU-Stern, Finance specialization). Founder: Vasuda Healthcare Analytics, premium research service covering emerging biotech/ pharma companies (in partnership with Seeking Alpha). Licensed Investment Advisor. Top-ranked analyst on Tipranks.
Insight Provider for Smartkarma Intelligent Investing (www.smartkarma.com): Institutional Investments Research Platform.
Buy-side equity research analyst covering mainly small-cap, emerging pharma/ biotech companies. M.D. with over 18 years of clinical experience (in the U.S. and India), still retaining full medical license in India. M.B.A. with finance and financial markets specialization from New York University Stern School of Business.
Expert in picking healthcare-related investments, especially biotechnology and pharmaceuticals (focus on small, emerging companies). Investments are selected based on detailed due diligence, including proprietary DCF valuation models. Value investor with long-term horizon.
Founder, managing principal of Vasuda Capital Management, healthcare focused investment management firm, vasudacapitalmanagement.com. Registered Investment Advisor in Massachusetts. The firm also operates a private investment partnership, Vasuda Life Sciences Fund.
Also started and continue to sponsor Vasuda Global Orphan/ Rare disease biotechnology index, the first global equity index covering rare/orphan disease sector. Index quotes are available on bloomberg/reuters terminals.
Brad Thomas is a research analyst and he currently writes weekly for Forbes and Seeking Alpha where he maintains research on many publicly-listed REITs. In addition, Thomas is the Senior Analyst at iREIT Forbes and Editor of the Forbes Real Estate Investor, a monthly subscription-based newsletter.
Thomas has also been featured in Forbes Magazine, Kiplinger’s, US News & World Report, Money, NPR, Institutional Investor, GlobeStreet, and Fox Business. He was the #1 contributing analyst on Seeking Alpha in 2014 (as ranked by TipRanks) and he is currently writing a book on the legendary investor Donald Trump.
Thomas has co-authored a book (The Intelligent REIT Investor) that is available on Amazon.
Thomas received a Bachelor of Science degree in Business/Economics from Presbyterian College where he played basketball. He resides in South Carolina with his wife and kids.
Born June 27th 1935 in Vienna, Austria. The youngest singer in my family which sang with the von Trapp singers, of which the film Sound of Music was based. Maria (played by Julie Andrew) was actually my nanny before she married Capt von Trapp (played by Christopher Plumber) who was not in the navy of Austria since Austria, being a land locked country, had no navy.
The little boy "Kurt" in the film was actually me. My mom never sued Twentieth Century Fox for using our story without receiving payment. (the von Trapps never went over the Alps to Switzerland.. that was my family and me...the captain and his singing family went to Italy and from there came to America via London)
When arriving in USA we moved to Arlington VT. where my neighbor was Norman Rockwell. My mom disallowed me from sitting for him despite frequent invitations to do so. Second immortality lost. :-)
Graduated with honors(Wall Street Journal award) from Lafayette College in 1957. After attending med school became ER physician in Conn. hospital, on the night shift. Had a seat on the NYSE at the same time and commuted from the hospital to Wall Street daily. After a few years of this, left medicine to stay with the NYSE Stock exchange.
Was also partner with Leon Cooperman in a NYSE member firm in late sixties. Carl Ichan and other notables of Wall Street are on best friends list..
Traded money for many well known names on the street such as Peter Kellogg of Spear Leeds and Kellogg, etc.
Am only surviving founder of the CBOE opened In early 70's. Names of "stripp, strapp, iron condor, condor, straddle, strangle" were all names that were thought up and first used by me. Traded options long before the CBOE was founded.
Traded on the CBOE under acronym PPP (known as Peter Paul) till 1988.
Started a Classic Jaguar restoration company in 1988 till 2011.
Went back to trading my own account, off floor in 2008.
60 years trading experience. Have been an avid technician the entire 60 years. We use fundamentals, PE ratios, overall market conditions, Fibonacci retracements, Elliott Wave theory, my own mathematical formulas as well as my own technical chart work (5 minute, daily, weekly as well as yearly) charts in analyzing and preparing recommendations to buy sell or hold.
ALL OUR ARTICLES are and will contain material discussion on timing and will be geared for the short term trader as well as the long term investor. I am on my computers, monitoring live charts and financial news on a minute to minute basis every trading day, from pre-market trading opening to after-market trades and the final closing.
Unlike Seeking Alpha articles from other contributors, all our articles will be prepared for maximum gain and minimum loss by supplying sell and buy stop recommendations along with the original recommendation. These will be updated as necessary over future time intervals. All will be published and added to all our recommendations on an "as needed" basis as often as market forces cause the need for such alterations. The use of option strategies as adjuncts or substitutions for stock will also be used and discussed as well as updated as necessary, so the investor taking our advise will never be out there "on his own" after acting on our initial recommendation from Doc's Trading"..
Readers may contact me directly at: firstname.lastname@example.org or (cell)928 951 4779
Alex Cho is a top contributor on Seeking Alpha in both the long ideas and technology section of the website. Alex Cho's articles have been featured on The Motley Fool, The Street, and Benzinga. Alex Cho has been featured on ValueWalk's throwback Thursday for his analysis on Apple. Furthermore, Alex Cho's financial expertise ranks him in the top 100 on TipRanks, and his recommendations have a 80% success rate according to Tip Ranks.
To reach out to him for business opportunities, to share ideas, guest writing opportunities, consulting opportunities e-mail him at email@example.com
Value Digger holds MSc. in Electrical Engineering, speaks four languages and has lived in the U.S. for many years. Also, he is a full-time investor and a freelance writer with one of the highest Followers per Article (F/A) rates in Seeking Alpha. His F/A rate in Seeking Alpha is above 30.
After creating "Nathan's Bulletin" (a subscription-based investment guide for investors who can't afford a financial advisor), Value Digger launched a subscription-based Premium Service in Seeking Alpha entitled "A Fundamental Investor's Stock Club" which includes an unparalleled, actively-managed and high-return Portfolio of unknown and/or underfollowed stocks. Regularly updated and detailed lists in his Premium Posts PROVE these high returns. For reference, when Value Digger was managing money in the early 2000s, his Portfolio's annual ROI consistently exceeded 50%. His Premium Research is based on a comprehensive review of company-specific factors, macro conditions, competitors and the industry trends.
When it comes to his publicly-available picks and his free Seeking Alpha articles, Value Digger is ranked in the TOP-50 with a success rate of over 80%, an average return per recommendation of over 30% and a 5-star rating according to TipRanks.com, which is the highest category quality ranking used to evaluate financial experts. TipRanks.com is a comprehensive investing tool that allows private investors and day traders to see the measured performance of anyone who publicly provides financial advice. TipRanks.com collects data, evaluates and ranks 9,000 financial experts worldwide.
After almost 30 years of investing experience in the international markets (U.S., Canada, Australia, Europe), Value Digger has formulated a deep understanding of valuation analysis and his investment philosophy is firmly grounded in Ben Graham-style value-oriented opportunities that often have an assymetric risk/reward profile. On that front, he has created a unique proprietary database with thousands of publicly-traded companies per sector, which helps him spot the bargains and the bubbles before many investors find them.
Founder of Disruptive Tech Research – a technology research and advisory firm serving the investment management community.
We provide registered investment professionals and qualified firms with independent, targeted research to support the generation of investment ideas.
We focus on patent-filing activity to identify the most promising disruptive technology trends early. Then, we employ an original, bottom-up fundamental research approach to uncover micro- and small-cap ideas that are underfollowed, underappreciated and undervalued.
Our mission is to provide clients with differentiated, actionable and thorough fundamental research at a cost effective price.
We’re 100% independent. That means absolutely no pay-to-play arrangements, no hidden agendas and no hype. Just solid research. And yes, we eat our own cooking.
I started my investment career at Morgan Stanley, where I helped direct over $1 billion in in institutional capital. After growing bored with the monotony of asset allocation studies, investment policy statements, manager searches and evaluations, and Retirement Plan Service Provider RFPs (among other things), I left and co-founded Wall Street Daily, which quickly became one of the web’s largest financial publishers with a daily circulation of more than 700,000 readers.
In 2014, I founded Disruptive Tech Research to pursue my investing passion, and fill the void in the market for high-quality, 100% independent research on disruptive technologies.
I have been fortunate to appear regularly on CNBC’s Closing Bell, as well as be mentioned in other media outlets, including in The Wall Street Journal, The New York Times, Morningstar and MarketWatch. I earned my MBA from the Crummer Graduate School of Business at Rollins College, which is also where I met my beautiful wife.
Pro Deo, Pro Familia, Pro Patria
For the past 30 years, I have been involved in startups, as a founder, and active investor. My first company was purchased by Johnson & Johnson, which set the foundation for future investments.
My level of trading escalated after graduating from college, primarily as a result of my relationship with the founder of the Silicon Valley venture capital firm, Institutional Venture Partners, (Netflix, Twitter, Oracle). By focusing on VC backed companies, I soon learned the advantage of investing in promising companies before they became household names. My interest in startups has never waned, and has become my primary focus today.
I am a Portuguese independent trader, analyst and algorithmic trading expert, having worked for both sell side (brokerage) and buy side (fund management) institutions.
I've been trading professionally for about 20 years and also launched www.thinkfn.com in 2004. Thinkfn (Think Finance) carries thousands of educational articles on finance and the markets.
I trade futures, stocks from the long and short side, forex and options. I trade both discretionary and fully automated systems (Metatrader, Quantshare and others).
I can be reached at paulo.santosATthinkfn.com or followed on Twitter at twitter.com/ThinkFinance999
Follow me on Twitter: @NewConstructs
David is CEO of New Constructs (www.newconstructs.com), an independent research firm that leverages proprietary technology to find key insights from the Financial Footnotes of 10Ks and 10Qs. Having analyzed over 70,000 annual reports and their Financial Footnotes, New Constructs helps protect clients from the red flags/unknowns in SEC filings.
David is a distinguished investment strategist and corporate finance expert. He is a member of FASB's Investors Advisory Committee, and he is author of the Chapter “Modern Tools for Valuation” in The Valuation Handbook (Wiley Finance 2010).
David's insights into the markets and his stock picks have been popular with a wide variety of media outlets.
Investview, Inc. Announces the Acquisition of a Majority Interest in Vickrey Brown Investments, LLC
The New Venture Could Potentially Add Significant Revenue And Will Expand Investview, Inc.'s Financial Investment Platform to Include the Development and Marketing of Exchange Traded Funds, Or Unit Investment Trusts (UITs).
RED BANK, NJ / ACCESSWIRE / August 12, 2014 / Investview, Inc. (INVU) ("Investview") announced today the acquisition of a majority interest in Vickrey Brown Investments, LLC, (VB) a Southern California company that specializes in investment strategies which combine quantitative strategies, forensic accounting and volatility controls. The acquisition adds a full range of quantitative investment strategies and analytical tools to Investview's current financial platform. Equally important, the acquisition could potentially increase Investview's revenue significantly.
VB Investments is founded by industry veterans Scott Brown and Donn Vickrey, PhD, CPA, CFE. Prior to forming VB Investments, Scott Brown was President and CEO of Sabrient Systems, LLC where he led the company to nearly $3 Billion in AUM and orchestrated the acquisition of Gradient Analytics. Revenues grew 4 fold during Brown's tenure at Sabrient as the company focused more on ETF and UIT creation. Dr. Donn Vickrey previously served as Director of Research at Gradient Analytics, an independent research provider he co-founded (with Dr. Carr Bettis) in 1996. During his tenure at Gradient Analytics, Dr. Vickrey was integral to the development of the firm's suite of quantitative investment models, including the first commercially available, quantitative model for assessing quality of earnings. He was also the primary architect behind the firm's signature Earnings Quality Analytics research service.
"The acquisition of VB investments is an important component to our Financial Services platform and will contribute significantly to increase revenues and assets under management in our RIA division." said Dr. Joseph Louro, Chief Executive Officer of Investview. "Our goal is to utilize our market proven analytics and technology to grow revenue in our Financial Services division" Louro continued.
"The majority stake by Investview provides us with the capability to further expand our product offerings as well as provide the necessary resources to significantly increase AUM for both firms," said Scott Brown, President and CEO of VB Investments.
About Investview, Inc.:
Investview, Inc. provides and delivers a comprehensive online program of investor education, offers proprietary investor search tools and trading indicators, distributes weekly newsletters and offers access to live weekly Trading Rooms. Recently Investview, under the direction of CEO Dr. Joseph Louro, has added a Financial Services Division which includes a Broker-Dealer, and a Registered Investment Advisory firm designed to utilize the firm's technology to generate reoccurring fees and commissions from potential Investview customers. For more information on any of the Investview products please visit: www.investview.com and www.vickreybrown.com
Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements
as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
For more information, please contact:
SOURCE: Investview, Inc.
Follow us on Twitter here: @theinvestar
Editor of theinvestar.com, LLC. theinvestar.com, LLC is a leading news provider on the potash and uranium mining industries supplying data services, commentary, interviews, investment news, newsletters and quarterly industry publications. If you would like to read other articles by theinvestar.com, or sign up for our newsletter (US$149.00/year). For more please visit our website or message us here on Seeking Alpha.
Director and Share Holder
Composer 15 Symphonies 4500 other works most published and sold world wide
UK tax expert
Computer manufacturer and sales manager
Retired age 48
Righting wrongs specialist
Winner of the
Let Get A Result From Bert Fish Hospital New Smyrna Beach Hospital Board of Directors.
A completely NON cell Phone User.
Richard Wagner fanatic
Georg Solti admirer
Vienna Philharmonic enthusiast
Free power free water free air advocate.
Anti Bank Of America enthusiast
A Do As You Would Be Done By and Be Done By As You Did advocate
Positive Thinking Artist
If It Isnt Broke DONT FIX IT PHD
Mariinsky Ballet lover
Tchaikovsky Glazonov Rimsky-Korsakov Musorgsky and Borodin enthusiast
Stravinsky Debussey Petipa fan.
Publisher of options newsletter TerrysTips.com since 2001.. Thirty years experience trading options virtually every day. including stint as seat holder and market maker on the C.B.O.E. MBA from Harvard Business School and DBA from Univ. of Virginia Darden School. Author of Making 36%: Duffer's Guide to Breaking Par in the Market Every Year, In Good Years and Bad (4th revision - 2012) and Coffee Can Investing: A Better Idea Than Mutual Funds in an IRA or 401(K), 2014.
TerrysTips.com is a newsletter that carries out eight different option portfolios which many subscribers mirror on their own or through auto-trade at several brokers who make all the same trades in individual customer accounts. Each portfolio offers something different (bullish, neutral, or bearish),and different underlyings (GOOG, SPY, SVXY, and other individual companies).
In 2005, the S.E.C. brought an action against Terry Allen, claiming that he was managing money for people without being a registered investment advisor because of the auto-trade service offered by several brokers who placed trades in their customer accounts based on Terry’s Tips newsletter recommendations. A second complaint was for a single statement on his website that they believed was incorrect and therefore fraudulent.
Although two large law firms assured Dr. Allen that if he went to court on the first issue, he would win because there was a Supreme Court decision stating that investment newsletters are exempt from registration requirements - it would be a violation of their First Amendment rights. However, they estimated that his legal expenses would be greater than settling with the S.E.C. (and a year or two of his time tied up in court proceedings), and both firms recommended that he accept the settlement offer while not admitting any guilt.
The second issue (fraud) involved a single statement that was true when it was written but a couple of years later, option prices fell to 10-year lows, and it was no longer true. The S.E.C. argued that the statement was not removed from the website in a timely enough fashion.
For the past eight years since the settlement with the S.E.C., Dr. Allen has have been publishing the Terry’s Tips newsletter (and recommendations are executed in customer accounts at thinkorswim by TD Ameritrade through their Auto-Trade program), and the S.E.C. has not objected to any of his activities.
Editor for The Biotech Forum (www.biotechforumsa.com), the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade. For Free weekly investment reports on small, attractive biotech stocks just register at www.bretjenseninvests.com